The ‘Skinny Trend’ and the Cost of Treating Weight as an Aesthetic
In recent times, the ‘Skinny Trend’ — a cultural shift towards extreme thinness to give a ‘heroin chic’ look— has taken over the media. In a time where 1 in 4 girls as young as eight are on a diet or actively trying to lose weight and with NHS England stating rates of eating disorders being four times higher in young women than men (20.8% compared to 5.1%) it is time to stop and ask how ‘harmless’ this trend truly is and what the cost is of weight as an aesthetic.
From Medical Treatment to Media Trend
Weight loss injections have become one of the most talked-about medical developments of recent years. GLP-1 receptor agonists — including drugs such as Ozempic, Mounjaro, and Wegovy — were initially prescribed to manage type 2 diabetes and obesity under clinical supervision. Now, they sit at the centre of a much broader cultural conversation, one that increasingly extends beyond health and into aesthetics. As their use becomes more widespread, so too do reports of side effects that are difficult to ignore. Among the most visible is hair loss — an issue frequently discussed across social media and online forums by people using GLP-1 medications. While not always listed as a primary side effect, clinicians acknowledge that hair shedding can occur, most often linked to rapid weight loss or physiological stress.
Hair loss experts say, hair loss is rarely the problem itself, it is a signal. This is because hair is one of the first things the body deprioritises when it’s under strain. When there’s sudden weight loss, reduced calorie intake, or nutrient imbalance, the body redirects resources to essential systems. Hair growth becomes secondary. This process, known as telogen effluvium, is not unique to weight loss injections. It has long been associated with crash dieting, illness, hormonal shifts and periods of significant stress. What makes its appearance in the context of GLP-1s notable is how clearly it illustrates a larger issue; the body does not experience weight loss in isolation. GLP-1 medications work by suppressing appetite, slowing gastric emptying and altering insulin response. In clinical settings, this can lead to improved metabolic markers and reduced risk for certain obesity-related conditions. But outside tightly monitored treatment plans, appetite suppression can also result in inadequate protein intake, vitamin deficiencies and loss of lean muscle mass — all of which affect the body systemically. In more serious cases there have been side effects of pancreatitis, gallbladder issues, kidney issues, and even Thyroid C-cell tumours.
Hair, skin, energy levels and menstrual cycles are often early indicators that something is out of balance. Yet culturally, these changes are frequently reframed as cosmetic inconveniences rather than physiological warnings. Online, it is now common to see people discussing how to “fix” hair loss caused by injections — through supplements, topical treatments or extensions — while continuing the medication uninterrupted. The focus remains on preserving appearance, rather than interrogating why the body is reacting in the first place. Medical professionals caution that the long-term effects of widespread GLP-1 use — particularly among people without metabolic conditions — and these are still being studied. While current data supports their effectiveness for weight loss, less is known about sustained use, cycling on and off the drugs, or their impact when combined with chronic under-fuelling.
The Aestheticization of Health
This compartmentalised approach mirrors a broader cultural shift. Weight loss, once framed primarily as a health intervention, is increasingly discussed as a neutral or even aesthetic choice. The body becomes something to optimise visually, rather than support holistically. Scroll through TikTok or Instagram today and weight loss content rarely looks like it did a decade ago. There are fewer before-and-after photos framed as “health journeys,” fewer references to cholesterol, blood pressure or longevity. Weight loss is still present — but it’s rarely named directly. What’s emerged in its place is a form of aesthetic minimalism that reframes weight loss as lifestyle refinement rather than health intervention. The shift is subtle but significant: success is no longer measured in medical outcomes, but in how little space the body seems to take up, both physically and narratively. In the 2010s, online weight loss content leaned heavily on transformation. Progress was quantified — kilograms lost, macros tracked, gym sessions logged. While often extreme or harmful, this content at least presented weight loss as something people did in pursuit of health, however narrowly defined. This evolution reflects broader changes in wellness culture. Health is no longer something you simply pursue; it is something you display. Platforms such as TikTok and Instagram reward visual clarity and simplicity — clean routines, curated meals, bodies that appear disciplined but effortless. Thinness folds seamlessly into this aesthetic. It signals control. It photographs well and asks for little explanation.
The Celebrity U-Turn
Perhaps the clearest indication of this shift is the public reversal of several celebrities once closely associated with body positivity. Figures like Lizzo, Oprah Winfrey, Rebel Wilson and even Amy Schumer built parts of their public image around rejecting narrow beauty standards and embracing larger bodies. Yet in recent years, many of these high-profile figures have openly discussed significant weight loss, some acknowledging the use of GLP-1 medications or similar interventions.
The language accompanying these transformations is strikingly similar:
‘I was unhappy.’ ‘
I did it for my health.’ ‘
I needed to feel better in my body’.
Those statements may well be true. Bodies are personal, and no one owes the public stasis, however, culturally, the messaging lands differently. When former advocates of body acceptance reposition thinness as a form of self-improvement or overdue “self-care,” it subtly reframes what confidence looks like. The implication becomes that liberation was temporary, and that true contentment was waiting on the other side of weight loss all along. The visual transformation reinforces an old hierarchy under a new vocabulary. What was once radical acceptance is softened into conditional acceptance — contingent on eventual reduction. For audiences who grew up seeing these women as proof that visibility did not require shrinkage, the reversal is not neutral. It feeds a quiet narrative that body positivity was a phase, and thinness remains the final form.
When Healthcare Reinforces the Message
Outside celebrity culture, the experience is often more intimate. For many women, a routine GP appointment can carry its own undercurrent of weight scrutiny. Symptoms unrelated to body size — fatigue, joint pain, irregular periods, even mental health concerns — are frequently met first with advice to lose weight. Sometimes this guidance is clinically relevant, however most commonly it is reflexive.
Research has long documented weight bias within healthcare settings, and patients consistently report feeling dismissed or reduced to a number on a chart. The result is not only frustration but avoidance: women delaying appointments, downplaying symptoms, or internalising the belief that their bodies are problems to be solved before they are people to be heard. When weight becomes the default explanation, it narrows medical imagination. Complex issues are flattened into a single metric, and even when weight loss is presented as supportive advice, the subtext can feel accusatory — as though thinness is the prerequisite for deserving thorough care. This mirrors the broader cultural script. If social media frames thinness as optimisation, and celebrities frame it as self-actualisation, healthcare can inadvertently frame it as moral responsibility. Across contexts, the body is measured first and understood second.
Who Set the Standard?
Which brings us to the question beneath the injections, the aesthetics, the before-and-afters: who decided the benchmark?
Body Mass Index — still widely used despite its well-documented limitations — was never designed as a nuanced measure of individual health. Beauty standards that privilege thinness, youth and narrow proportions have historically centred wealth, whiteness and male-dominated industries. Yet these are the metrics against which millions of women quietly calibrate and hate themselves on. We are comparing living, hormonal, fluctuating bodies to standards shaped in boardrooms, fashion houses and tech platforms — industries disproportionately led by affluent, powerful men. Many of those same power structures are now under scrutiny for exploitative labour practices, discrimination, harassment, and criminal misconduct. And yet their aesthetic ideals remain largely unquestioned. The irony is difficult to ignore; we are shrinking ourselves to fit systems that are themselves ethically unstable. The “Skinny Trend” is not simply about fashion or medication. It is about authority — who gets to define health, desirability and success. When weight is treated as an aesthetic rather than a complex biological variable, the body becomes a site of compliance. And when thinness is framed as neutral, inevitable, or morally superior, dissent begins to look like failure.
Perhaps the real question is not whether GLP-1s work, or whether celebrities are entitled to change their minds, or even whether weight loss can improve certain health outcomes. It is this: why does smaller still mean better? And who benefits most from us believing that it does? Until we interrogate the origin of the yardstick, we will keep measuring ourselves against it — even when the scale was never built for us in the first place.
Part three of this series will discuss bringing back awareness and connection to our bodies and their vital systems.
Written by Rochelle Hanslow
